Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TMEM2 Combined with IDH and 1p19q in Refining Molecular Subtypes for Predicting Survival of Patients with Glioma.

DNA and cell biology - 1 Nov 2021

Jiang Qiuyi, Wang Xinzhuang, Yang Quan, Zhang Hong, Wang Xiaoxiong

Abstract excerpt

Gliomas are common intracranial tumors with high morbidity and mortality in adults. Transmembrane protein 2 (TMEM2) is involved in the malignant behavior of solid tumors. TMEM2 regulates cell adhesion and metastasis as well as intercellular communication by degrading nonprotein components of the extracellular matrix. This study aimed to evaluate the relationship between TMEM2 expression levels and glioma subtypes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Chromosomes, Human, Pair 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosomes, Human, Pair 19

Share to Computational Biology

Share to Databases, Genetic

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Tumor Microenvironment

Source

Identifiers

PMID: 34735293
DOI: 10.1089/dna.2020.6384

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TMEM2 Combined with IDH and 1p19q in Refining Molecular Subtypes for Predicting Survival of Patients with Glioma.PMID 34735293Read ↗

Integrated Analysis Identifies MEOX2 as a Malignant Driver and Prognostic Biomarker in Brain GliomaSemantic proximity Read ↗

Systematic Identification of UBE2C As a Prognostic Biomarker and Correlated with Immunosuppression and Invasiveness in GliomaSemantic proximity Read ↗

Systematic Identification of UBE2C As a Prognostic Biomarker and Correlated with Immunosuppression and Invasiveness in GliomaSemantic proximity Read ↗

B2M overexpression correlates with malignancy and immune signatures in human gliomas.Semantic proximity Read ↗

[Advances of glioma biomarkers].Semantic proximity Read ↗

New insights into glioma classification based on isocitrate dehydrogenase 1 and 2 gene status.Semantic proximity Read ↗

FXYD2 mRNA expression represents a new independent factor that affects survival of glioma patients and predicts chemosensitivity of patients to temozolomide.Semantic proximity Read ↗

UBE2C is associated with Prognosis of Immunosuppression and Cell Invasiveness in GliomaSemantic proximity Read ↗

FXYD2 mRNA Expression Represents a New Independent Factor That Affects Survival of Glioma Patients and Predicts Chemosensitivity of Patients to TemozolomideSemantic proximity Read ↗

M2 TAM-related risk signature based on single-cell and bulk RNA sequencing to evaluate tumor immune microenvironment and predict prognosis in gliomaSemantic proximity Read ↗

ECM-based molecular subtypes define prognostic, EMT status, and therapeutic diversity in IDH-mutant gliomasSemantic proximity Read ↗

IDH1/2 mutation status combined with Ki-67 labeling index defines distinct prognostic groups in glioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.